Yusoff 2015 InTech

From Bioblast
Revision as of 23:07, 3 August 2023 by Gnaiger Erich (talk | contribs) (Created page with "{{Publication |title=Yusoff AAM, Ahmad F, Idris Z, Jaafar H, Abdullah JM (2015) Understanding mitochondrial DNA in brain tumorigenesis. In: Lichtor T, ed. Molecular considerat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Yusoff AAM, Ahmad F, Idris Z, Jaafar H, Abdullah JM (2015) Understanding mitochondrial DNA in brain tumorigenesis. In: Lichtor T, ed. Molecular considerations and evolving surgical management issues in the treatment of patients with a brain tumor. InTech: http://dx.doi.org/10.5772/58965

Β» Open Access

Yusoff AAM, Ahmad F, Idris Z, Jaafar H, Abdullah JM (2015) InTech

Abstract: In developed countries, most studies reveal that the number of people who develop brain tumors and die from them has increased. Brain tumor, one of the most devastating central nervous system pathologies, is the leading cause of solid tumor death in children under the age of 15, and the second leading cause of cancer death in male adults ages 20-39. So far, researches on genesis and development of tumor are intensively focused and studied on alteration of the gene in nucleus and brain tumors is the one where most were reported arise as the result of progressive nuclear genetic alterations. Multiple genetic events have been identified in brain tumor cells involving some well-known susceptibility genes such as tumor suppressor and oncogenes that are encoded by the nuclear DNA (nDNA). For instance, the p53 tumor suppressor gene is frequently mutated and often detected altered or lost early in brain tumor mainly in astrocytic tumors formation [1-3]. Similarly, mutations or loss of PTEN (phosphatase and tensin homolog), p16, RB (retinoblastoma) and amplification of EGFR (epidermal growth factor receptor), MDM2, CDK4, CDK6 (cyclin-dependent kinase) are also involved in the pathogenesis of brain tumor [4,5].

β€’ Bioblast editor: Gnaiger E


Labels: Pathology: Cancer 

Organism: Human  Tissue;cell: Nervous system 

Enzyme: Complex II;succinate dehydrogenase 




Yusoff 2015 InTech CORRECTION.png

Correction: FADH2 and Complex II

Ambiguity alert.png
FADH2 is shown as the substrate feeding electrons into Complex II (CII). This is wrong and requires correction - for details see Gnaiger (2024).
Gnaiger E (2024) Complex II ambiguities ― FADH2 in the electron transfer system. J Biol Chem 300:105470. https://doi.org/10.1016/j.jbc.2023.105470 - Β»Bioblast linkΒ«
Cookies help us deliver our services. By using our services, you agree to our use of cookies.